ISSN 2472-0429
Advances in Cancer Prevention
Open Access
Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)Recommended Conferences
- 25th Cancer Nursing and Nurse Practitioners Conference
July 17-18, 2017 Libson, Portugal - 19th Euro Congress on Cancer Science and Therapy
July 20-22, 2017 Lisbon, Portugal - 9th International Conference and Expo on Molecular and Cancer Biomarkers
August 23-24, 2017 Birmingham, UK - International Conference on Cancer Diagnostics
November 27- 28, 2017 Dubai, UAE
Recommended Journals
Relevant Topics
- 3D Mammograms
- Alternative Cancer Medicines
- Anal Cancer Diagnosis
- Aromatase Inhibitors
- Asbestos
- Astrocytoma
- Biomarkers and Molecular Diagnosis of all Gynaecologic Cancers
- Bladder Cancer Diagnosis
- Bladder Carcinoma in Situ
- Blood Cancer Diagnosis
- Brain Cancer Diagnosis
- Brain Metastasis
- Brain Tumour
- Brainstem Compression
- Breast Cancer Diagnosis
- Breast Reconstruction Surgery
- COPD
- Cancer Diagnosis
- Cancer Immunoediting
- Cancer Immunology
- Cancer Immunotherapies
- Cancer Prevention from Nuts
- Cancer Radioimmunotherapy
- Cancer Screening
- Cancer and Nutrition
- Cellular Immunotherapy
- Cellular Oncology
- Central Neurocytoma
- Cervical Cancer Diagnosis
- Cervical Erosin
- Chemoprevention
- Chemotherapies
- Clinical Gynecologic Oncology
- Clinical Oncology
- Colon Cancer Diagnosis
- Comparative Oncology
- Cysts and Ovaries
- Dental Oncology
- Dietary Supplements
- Dyspnea
- Epidemiology of Gynecologic Cancers
- Esophageal Cancer Diagnosis
- Exercise and Cancer
- Fallopian Tube Cancer
- Genitourinary Oncology
- Gestational Trophoplastic Tumors
- Glioblastoma
- Glioblastoma Multiforme
- Glioma
- Gynecological Oncology
- Immune Suppression
- Immunogene response
- Immunosurveillance
- Immunotherapeutic agents
- Immunotherapy or biologic therapy
- Interventional Oncology
- Intracranial Metastasis
- Intracranial Neoplasm
- Kidney Cancer Diagnosis
- Leukemia Diagnosis
- Liver Cancer Diagnosis
- Lung
- Lung Cancer
- Lung Cancer Diagnosis
- Lung Cancer Facts
- Lung Cancer Prognosis
- Lung Cancer Stages
- Lung Cancer Survival Rate
- Lung Cancer Symptoms in Women
- Lung Cancer Treatment
- Lung Diseases
- Lymphoma Diagnosis
- Meningeal carcinomatosis
- Meningioma
- Mesothelioma
- Mesothelioma Diagnosis
- Metastasis
- Metastatic Brain Tumour
- Molecular Oncology
- Mouth Cancer Diagnosis
- Multiple Endocrine Neoplasia
- Musculoskeletal Oncology
- Naturopathic Treatments
- Necrosis
- Nerve Sheath Tumours
- Neuroblastoma
- Neuroblastoma Cancer
- Neurofibromatosis
- Nucleic Acid Research
- Omentum Cancer
- Oncology Analytics
- Oncology Emergency
- Oncology Esthetics
- Oncology Nutrition
- Oncoplastic Surgery
- Ovarian Cancer
- Ovarian Cancer Diagnosis
- Ovarian Cancer Prognosis
- Ovarian Tumors
- Pancreatic Cancer Diagnosis
- Pathological aspects and molecular pathology of all Gynecologic Cancers
- Pituitary Adenoma
- Primary Peritoneal Cancer
- Primary Spinal Cord Tumors
- Prostate Cancer Diagnosis
- Quality of Life of Patients with Gynecologic Cancers
- Radio Oncology
- Rectal Cancer Diagnosis
- Reproductive Cancer
- Scintimammography
- Signs of Lung Cancer
- Skin Cancer Diagnosis
- Skull Metastasis
- Small Cell Lung Cancer
- Socio- Psychological Aspects of Gynecological Cancers
- Stage 4 Lung Cancer
- Stem Cell Transplants for Cancer Prevention
- Symptoms of Lung Cancer
- Systems of Immune
- Targeted Molecular Therapy for all Gynaecologic Cancers
- Testicular Cancer Diagnosis
- Thoracic Oncology
- Thyroid Cancer Diagnosis
- Transitional cell carcinoma (TCC)
- Tumor Immunity
- Tumour Immunity
- Tumour Immunology
- Types of Lung Cancer
- Uterine Cancer
- Uterine Cancer Diagnosis
- Vaginal Cancer
- Veterinary Oncology
- Vulva Cancer
- Womb Cancer
Batalden RP |
||
| Batalden RP, Massachusetts General Hospital, Department Obgyn, Division of Female Pelvic Medicine and Reconstructive Surgery, USA. | ||
| Biography | ||
|
Dr. Rebecca Batalden is an obstetrician-gynecologist in Boston, Massachusetts. She received her medical degree from Saint Louis University School of Medicine and has been in practice for 8 years.
|
||
| Research Interest | ||
Scintimammography, 3D Mammograms, Chemoprevention, Aromatase Inhibitors |
||
| Publications | ||
|
Uterine Pathology in Hysterectomies Performed for Treatment of Pelvic Organ Prolapse Foust-Wright CE, Pilliod RA, Weinstein MM, Johnson AM, Batalden RP and Pulliam SJ Research Article: Adv Cancer Prev 2016, 1: 101 |
||
Global Speakers in the subjectGlobal Experts in the subject |
||
Relevant Conferences
- Cancer
Cancer Meeting 2017 (singapore) - Cancer Biology
Cancer Meeting 2017 (singapore) - Cancer Case Reports
Cancer Meeting 2017 (singapore) - Cancer Diagnosis and Cancer Diagnostics
Cancer Meeting 2017 (singapore) - Cancer Epidemiology
Cancer Meeting 2017 (singapore) - Cancer Genetics
Cancer Meeting 2017 (singapore) - Cancer Management and Prevention
Cancer Meeting 2017 (singapore) - Cancer screening
Cancer Meeting 2017 (singapore) - Novel Approaches to Cancer Therapeutics
Cancer Meeting 2017 (singapore) - Obesity and Cancer
Cancer Meeting 2017 (singapore) - Oncogenomics
Cancer Meeting 2017 (singapore) - Oncology and Hematology
Cancer Meeting 2017 (singapore) - Precision Medicine and Cancer Therapy
Cancer Meeting 2017 (singapore) - Resistance and Tumor Evolution
Cancer Meeting 2017 (singapore) - Stem Cell Therapy
Cancer Meeting 2017 (singapore) - Antibody Therapy of Cancer
Tumor & Cancer immunology 2017 (USA) - Brain Tumors
Tumor & Cancer immunology 2017 (USA) - Cancer biomarkers
Tumor & Cancer immunology 2017 (USA) - Cancer clinical trials
Tumor & Cancer immunology 2017 (USA) - Cancer Immunology & Immunotherapy
Tumor & Cancer immunology 2017 (USA) - Cancer micro and immuno environment
Tumor & Cancer immunology 2017 (USA) - Cancer Research
Tumor & Cancer immunology 2017 (USA) - Cancer vaccines
Tumor & Cancer immunology 2017 (USA) - Combining Cancer Immunotherapies
Tumor & Cancer immunology 2017 (USA) - Engineered T-Cell Therapy
Tumor & Cancer immunology 2017 (USA) - Immune checkpoint inhibitors
Tumor & Cancer immunology 2017 (USA) - Immuno-Oncology studies
Tumor & Cancer immunology 2017 (USA) - Immunotherapy - Tumors
Tumor & Cancer immunology 2017 (USA) - Immunotherapy Monitoring
Tumor & Cancer immunology 2017 (USA) - Novel Approaches in Cancer & Tumor
Tumor & Cancer immunology 2017 (USA) - Tumor biology
Tumor & Cancer immunology 2017 (USA) - Tumor Immunogenicity
Tumor & Cancer immunology 2017 (USA) - Tumor Immunology
Tumor & Cancer immunology 2017 (USA) - Tumor immunotherapy research
Tumor & Cancer immunology 2017 (USA) - Tumor markers and drug targeting
Tumor & Cancer immunology 2017 (USA) - Tumorigenesis
Tumor & Cancer immunology 2017 (USA) - Tumors
Tumor & Cancer immunology 2017 (USA) - Cancer Biomarkers
Cancer Diagnostics Conference (UAE) - Cancer Case Reports and Awareness
Cancer Diagnostics Conference (UAE) - Cancer Diagnostics - Types
Cancer Diagnostics Conference (UAE) - Cancer Diagnostics Market
Cancer Diagnostics Conference (UAE) - Cancer Screening Tests
Cancer Diagnostics Conference (UAE) - Cancer Therapies
Cancer Diagnostics Conference (UAE) - Cancer Treatment
Cancer Diagnostics Conference (UAE) - Entrepreneurship Meet
Cancer Diagnostics Conference (UAE) - Organ Specific Cancer
Cancer Diagnostics Conference (UAE) - Recent Diagnostics Technologies
Cancer Diagnostics Conference (UAE)
